Week 387 Review - Great start to the New Year

A really good week, with gains all over the portfolio, lots of 8% gains and a 1p rise in OPTI:Optibiotix. That narrowed the deficit between cost and value by £4,212 to £114,439 and increased portfolio value to £68,780.

There were no big fallers this week.

OPTI:Optibiotix climbed 1p, which is 5% in my trading holdings. It was on the back of a good update from PBX:Probiotix Health which also rose by 5%. However, that wasn't the great news I was hoping for so I sold my purchased holding at a loss so I have ammo for when the share price collapses following the end of the lock-in.

RIO:Rio Tinto is one of my most recent magic formula shares and climbed 5% to go 3% into profit.

TRX:Tissue Regenix was the last of the 5% risers. There was no particular news, but things seem to be improving for them and I'm still hopeful they will eventually become profitable or get bought out.

ANTO:Antofagasta is another recent magic formula purchase and climbed 8% this week to go 13% up altogether, so I can now set a virtual stop loss at 3% to guarantee I don't make a loss. Really hoping it never gets triggered though.

CAML:Central Asia Metals also rose 8% as most of the metal producers had a good week. They are now 17% up and making potential profit of £579, so the virtual stop loss is increased to 7%. 

The last 8% riser was NUM:Numis Corp. These have been desperately disappointing so far, but climbed to a 25% loss so at least went from orange/red to orange in the colour coding.

Share of the Week goes to CEY:Centamin. They have been a bit rubbish for the 18 months or so I've held them, but climbed 11% this week to go into profit by 7%. With an additional 8% in dividends these are now looking much more respectable.

Well, it's a tick up, but can it be sustained?

Above the trend line!

Here's the ISA and shares portfolio after week 23 of year 8.

			Weekly Change
Cash	£15.20		+£0
Portfolio cost	£82,163.25		+£0
Portfolio sell value (bid price-commission)	£26,294.89	(-68.0%)	+£2,109.33
Potential profits	£0		+£0
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0.05		+£0
Yr 8 Profit from sales	-£995.63		+£0
Yr 8 projected avg monthly profit	-£191.11	(-5.2%)	+£17.42
Total Dividends	£11,768.92		+£0
Total Interest	£0.05		+£0
Total Profit from sales	£27,098.43		+£0
Average monthly cash profit	£431.34	(11.6%)	-£2.28
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	87%		+0%

Pretty quiet, but nice rise of £2,109 in value. I have just over six months to try and make £1,000 profit to overturn the Year 8 deficit.

Doesn't look like a convincing up-tick

Above the trend line but it's going to take some turning around.

The SIPP looks like this after week 371 overall and week 7 of year 8.

			Weekly Change
Cash	£1,857.76		+£1,513.05
Portfolio cost	£97,334.43		-£1,114.44
Portfolio sell value (bid price - commission)	£40,015.38	(-58.9%)	+£1,114.44
Potential profits	£795.77		+£452.44
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0.03		+£0.02
Yr 8 Profit from sales	-£67.32		-£161.73
Yr 8 projected avg monthly profit	-£55.61	(-1.1%)	-£114.40
Total Dividends	£14,142.78		+£0
Total Interest	£0.28		+£0.02
Total Profit from sales	£20,366.43		-£161.73
Average monthly cash profit	£391.17	(7.9%)	-£3.07
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	56%		-1%

I sold the PBX:Probiotix shares I bought on the market when they went up to 20p. It was 6,740 shares and I made a loss pf £161.73 (-10.8%), but liberated £1,338.05 for when the share price tanks after the lock-in ends and I can buy at least twice as many.

Great increase in potential profits of £452, with CEY:Centamin and RIO:Rio Tinto both going into profit and joining ANTO:Antofagasta and CAML:Central Asia Metals which also had good gains.

The sale rather spoiled my Year 8 performance, sending it negative, but it had to be done to limit my losses from the misguided purchase of PBX on the open market.

Will we ever see those meteoric rises that sent the value back above the injection line twice in the last 12 months?

Need about £20k improvement to flatten the trend line. OPTI:Optibiotix climbing to 40p would do that. Unfortunately DDDD:4D Pharma and PBX:Probiotix are about to absolutely tank and cost me about the same amount.

The trading account looks like this after week 337 overall and week 25 of year 7.

			Weekly Change
Cash	£0.10		+£0
Portfolio cost	£1,849.21		+£0
Portfolio sell value (bid price - commission)	£597.13	(-67.7%)	+£24.69
Potential profits	£0		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.01		+£0
Year 7 Profit	-£71.73		+£0
Yr 7 projected avg monthly profit	-£12.43	(-8.1%)	+£0.52
Dividends	£60.10		+£0
Interest	£0.01		+£0
Profit from sales	£154.87		+£0
Average monthly cash profit	£2.76	(1.8%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

The 1p increase in OPTI:Optibiotix sees a small rise for the second week. Still a long way from being able to sell. At least there is now some slim hope DDDD:4D Pharma will survive, albeit massively diluted. I'll have to take the loss as it will be a decade before they get back to the purchase price in this account.

Slow and steady - for now...

Tragically still below the trend line

It's very encouraging that the year started so well. I don't know how long it will last, but will enjoy it while I can.